Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 08:53 am Sale | 13G | SIO GENE THERAPIES INC SIOX | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0% | -5,914,000 (Position Closed) | View |
| 2023-02-10 4:00 pm Purchase | 13G | SIO GENE THERAPIES INC SIOX | Rubric Capital Management LP | 7,000,000 9.46% | 7,000,000 (New Position) | View |
| 2022-02-14 1:57 pm Sale | 13G | SIO GENE THERAPIES INC SIOX | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2022-02-11 4:45 pm Purchase | 13G | SIO GENE THERAPIES INC SIOX | SUVRETTA CAPITAL MANAGEMENT LLC | 5,914,000 8.1% | 425,000 (+7.74%) | View |
| 2021-02-26 4:24 pm Purchase | 13G | SIO GENE THERAPIES INC SIOX | SUVRETTA CAPITAL MANAGEMENT LLC | 5,489,000 8.6% | 5,489,000 (New Position) | View |
| 2021-02-16 4:27 pm Unchanged | 13G | SIO GENE THERAPIES INC SIOX | Consonance Capital Management LP | 6,058,505 9.99% | 0 (Unchanged) | View |
| 2021-02-16 2:40 pm Purchase | 13G | SIO GENE THERAPIES INC SIOX | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |
| 2021-02-16 09:00 am Unchanged | 13G | SIO GENE THERAPIES INC SIOX | SPHERA FUNDS MANAGEMENT LTD. | 0 0% | 0 (Unchanged) | View |
| 2020-02-27 9:59 pm Purchase | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 18,577,380 47.1% | 5,333,333 (+40.27%) | View |
| 2020-02-25 11:18 am Purchase | 13G | AXOVANT GENE THERAPIES LTD COM AXGT | SPHERA FUNDS MANAGEMENT LTD. | 2,931,017 7.96% | 2,931,017 (New Position) | View |
| 2020-02-13 12:43 pm Unchanged | 13G | AXOVANT GENE THERAPIES LTD COM AXGT | Flynn James E | 0 0% | 0 (Unchanged) | View |
| 2020-02-11 12:16 pm Sale | 13G | AXOVANT GENE THERAPIES LTD COM AXGT | SPHERA FUNDS MANAGEMENT LTD. | 398,540 1.75% | -7,801,460 (-95.14%) | View |
| 2019-12-31 4:45 pm Unchanged | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 13,244,047 58.1% | 0 (Unchanged) | View |
| 2019-09-06 5:06 pm Unchanged | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 13,244,047 58.1% | 0 (Unchanged) | View |
| 2019-07-16 6:00 pm Unchanged | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Lo Andrew | 0 0% | 0 (Unchanged) | View |
| 2019-07-16 5:31 pm Sale | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Machado Patrick | 0 0% | -105,952,381 (Position Closed) | View |
| 2019-07-16 5:30 pm Sale | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 13,244,047 58.1% | -92,708,334 (-87.50%) | View |
| 2019-07-15 09:22 am Sale | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | VIKING GLOBAL INVESTORS LP | 0 0% | -105,952,381 (Position Closed) | View |
| 2019-07-12 5:06 pm Unchanged | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | QVT Financial LP | 0 0% | 0 (Unchanged) | View |
| 2019-07-12 4:47 pm Sale | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Dexxon Holdings Ltd. | 0 0% | -105,952,381 (Position Closed) | View |